SCHEMBL28548957

SCHEMBL28548957

Cc1cc(Nc2cc(-c3ccccc3)nc(S(=O)(=O)c3ccc(NC(=O)C(C)C)cc3)n2)[nH]n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 2/20 0.44
▸ ADORA3 P0DMS8 1/20 0.44
▸ ADORA2A P29274 1/20 0.44
▸ MEN1 O00255 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ AURKA O14965 2/20 0.41
▸ AURKB Q96GD4 2/20 0.40
▸ ALDH1A1 P00352 4/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ MAPT P10636 2/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ LMNA P02545 1/20 0.37
▸ CNR1 P21554 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ GPR55 Q9Y2T6 1/20 0.37
▸ CA12 O43570 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28557357 0.90 AURKB (0.49) ADORA1ADORA3ADORA2AMEN1KMT2A
SCHEMBL28022116 0.89 ADORA1 (0.47) ADORA1ADORA3ADORA2AMEN1KMT2A
SCHEMBL28021591 0.88 AURKB (0.51) ADORA1ADORA3ADORA2AMEN1KMT2A
SCHEMBL28553059 0.86 ADORA1 (0.45) ADORA1ADORA3ADORA2AMEN1KMT2A
SCHEMBL28022051 0.86 HRH4 (0.41) SMN1; SMN2AURKAAURKBMAPTPOLB
SCHEMBL28570220 0.86 BPTF (0.38) MEN1KMT2ASMN1; SMN2AURKAAURKB
SCHEMBL28565368 0.85 AURKB (0.44) MEN1KMT2ASMN1; SMN2NPC1AURKA
SCHEMBL28022063 0.83 SMN1; SMN2 (0.42) MEN1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL28549341 0.83 ALDH1A1 (0.45) MEN1KMT2ANPC1AURKBALDH1A1
SCHEMBL2200635 0.81 AURKB (0.61) ADORA1ADORA3ADORA2AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112755193-A Method of treating malignancies with anti-tyrosine kinase inhibitors using dianhydrogalactitol or a derivative thereof 德玛医药 2021-05-07 — — CN disclosed
Send feedback